BridgeBio have significantly advanced this course of an innovative therapy for amyloid heart disease, employing Attruby. Early trial results suggests potential improvements for patients affected from a severe illness. https://attr-cm509537.madmouseblog.com/22879900/company-improves-cardiac-amyloidosis-management-with-the-drug